A detailed history of Voya Investment Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Voya Investment Management LLC holds 52,862 shares of NVCR stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,862
Previous 72,930 27.52%
Holding current value
$1.7 Million
Previous $1.25 Million 33.87%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.61 - $23.34 $313,261 - $468,387
-20,068 Reduced 27.52%
52,862 $826,000
Q2 2024

Dec 03, 2024

BUY
$11.83 - $24.05 $237,404 - $482,635
20,068 Added 37.96%
72,930 $1.25 Million
Q2 2024

Aug 14, 2024

SELL
$11.83 - $24.05 $153,506 - $312,072
-12,976 Reduced 15.1%
72,930 $1.25 Million
Q1 2024

Dec 06, 2024

BUY
$12.42 - $17.29 $410,406 - $571,330
33,044 Added 62.51%
85,906 $1.34 Million
Q1 2024

May 15, 2024

SELL
$12.42 - $17.29 $918,819 - $1.28 Million
-73,979 Reduced 46.27%
85,906 $1.34 Million
Q4 2023

Feb 14, 2024

BUY
$11.13 - $15.78 $872,113 - $1.24 Million
78,357 Added 96.11%
159,885 $2.39 Million
Q3 2023

Nov 14, 2023

SELL
$16.15 - $42.35 $4.95 Million - $13 Million
-306,791 Reduced 79.0%
81,528 $1.32 Million
Q2 2023

Aug 14, 2023

BUY
$40.29 - $82.51 $4.3 Million - $8.81 Million
106,758 Added 37.92%
388,319 $16.1 Million
Q1 2023

May 15, 2023

SELL
$56.44 - $118.81 $2.19 Million - $4.61 Million
-38,774 Reduced 12.1%
281,561 $16.9 Million
Q4 2022

Feb 14, 2023

BUY
$63.98 - $85.37 $1.64 Million - $2.18 Million
25,576 Added 8.68%
320,335 $23.5 Million
Q3 2022

Mar 03, 2023

SELL
$67.99 - $89.57 $1.74 Million - $2.29 Million
-25,576 Reduced 7.98%
294,759 $22.4 Million
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $2.8 Million - $3.69 Million
41,175 Added 16.24%
294,759 $22.4 Million
Q2 2022

Aug 15, 2022

SELL
$56.6 - $89.9 $721,536 - $1.15 Million
-12,748 Reduced 4.79%
253,584 $17.6 Million
Q1 2022

May 16, 2022

SELL
$60.15 - $84.52 $425,380 - $597,725
-7,072 Reduced 2.59%
266,332 $22.1 Million
Q4 2021

Feb 14, 2022

SELL
$75.08 - $121.99 $12.6 Million - $20.5 Million
-168,033 Reduced 38.07%
273,404 $20.5 Million
Q3 2021

Nov 15, 2021

BUY
$116.17 - $194.55 $15.8 Million - $26.4 Million
135,596 Added 44.34%
441,437 $51.3 Million
Q2 2021

Aug 16, 2021

SELL
$130.4 - $225.58 $26.6 Million - $46.1 Million
-204,315 Reduced 40.05%
305,841 $67.8 Million
Q1 2021

May 17, 2021

BUY
$124.11 - $190.17 $15.4 Million - $23.7 Million
124,391 Added 32.25%
510,156 $67.4 Million
Q4 2020

Feb 16, 2021

SELL
$112.16 - $174.14 $17.6 Million - $27.3 Million
-157,047 Reduced 28.93%
385,765 $66.8 Million
Q3 2020

Nov 16, 2020

SELL
$58.05 - $111.31 $14 Million - $26.9 Million
-241,788 Reduced 30.82%
542,812 $60.4 Million
Q2 2020

Aug 14, 2020

BUY
$57.2 - $74.41 $34.8 Million - $45.2 Million
607,605 Added 343.29%
784,600 $46.5 Million
Q1 2020

May 15, 2020

SELL
$57.05 - $95.75 $7.55 Million - $12.7 Million
-132,342 Reduced 42.78%
176,995 $11.9 Million
Q4 2019

Feb 14, 2020

SELL
$68.3 - $93.8 $3.84 Million - $5.27 Million
-56,200 Reduced 15.37%
309,337 $26.1 Million
Q3 2019

Nov 14, 2019

BUY
$61.86 - $97.8 $20.5 Million - $32.5 Million
332,111 Added 993.57%
365,537 $27.3 Million
Q2 2019

Aug 14, 2019

BUY
$42.22 - $63.23 $150,978 - $226,110
3,576 Added 11.98%
33,426 $2.11 Million
Q1 2019

May 15, 2019

SELL
$31.96 - $56.12 $16,523 - $29,014
-517 Reduced 1.7%
29,850 $1.44 Million
Q4 2018

Feb 14, 2019

BUY
$28.72 - $52.63 $60,541 - $110,944
2,108 Added 7.46%
30,367 $1.02 Million
Q3 2018

Nov 14, 2018

BUY
$32.0 - $52.4 $10,528 - $17,239
329 Added 1.18%
28,259 $1.48 Million
Q2 2018

Aug 14, 2018

BUY
$19.85 - $32.0 $36,007 - $58,048
1,814 Added 6.95%
27,930 $874,000
Q1 2018

May 15, 2018

SELL
$19.3 - $23.65 $13,027 - $15,963
-675 Reduced 2.52%
26,116 $569,000
Q3 2017

Nov 14, 2017

BUY
$18.05 - $21.75 $483,577 - $582,704
26,791
26,791 $532,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.37B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.